Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel therapies and solutions for neurological and oncological diseases with urgent unmet medical need. Besides of using Lumosa's own technology platform in drug development, the company is also actively engaged in scientific licensing and co-development collaboration, building a pipeline from early to late-stage assets consisting of first-in-class and best-in-class drug products through leveraging the company’s broad global network and drug development competence.
Enrich the quality of life through pioneering medical science, diverse collaborations, and the commitment to remain genuine and ever-evolving. Lumosa develops all aspects of talent in creative ways encouraging employees to exploit their strengths regardless of their positions to lead and inspire others.
Sustainability
Partnership
Efficiency
Elite
Diligence
Global innovator with pathbreaking solution in Neuroscience, especially in stroke